Post-Surgical Corticosteroid Eye Drops: Additives for Storage pH Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current ocular treatments face challenges in delivering effective drug doses due to passive diffusion limitations, and cyclodextrin-based eye drops experience pH instability during storage, necessitating a method to stabilize the pH and prevent drug oxidation.

Innovation Solution

The addition of an additive, such as antioxidants or oxygen scavengers, to the aqueous composition comprising a drug, particularly corticosteroids, stabilizes the pH by preventing oxidation, especially during long-term storage.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If cyclodextrin-based eye drops are stored in low-density polyethylene vials for several months, then the convenience of storage is improved, but the pH stability deteriorates and decreases over time

Engineering Contradiction:
Improvestorage convenienceVSAvoidpH stability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

An antioxidant additive is introduced as an intermediary substance to prevent oxidation reactions between the corticosteroid drug and oxygen in the aqueous environment. This mediator protects the drug from degrading into acidic products that would lower pH, thereby maintaining pH stability during storage in convenient LDPE vials

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The chemical environment parameters of the aqueous composition are modified by adding antioxidants that change the oxidation-reduction state of the system. This prevents the formation of acidic degradation products and maintains the pH parameter stable over several months of storage

Inventive Principle:
Principle #35Parameter changes

2Duration of action of stationary object

If corticosteroid eye drops are stored for long-term periods, then the duration of availability is improved, but oxidation of the drug occurs leading to pH decrease

Engineering Contradiction:
Improvestorage durationVSAvoiddrug oxidation and acidic degradation
Core Design Contradiction:
Duration of action of stationary objectVSObject-generated harmful factors

Solution Approach 1:

Antioxidant additives are incorporated into the eye drop formulation in advance before storage begins. This preliminary protective action prevents oxidation reactions from occurring during long-term storage, thereby preventing the formation of acidic degradation products and maintaining pH stability throughout the storage period

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The potential harmful effect of oxygen present in the aqueous environment is converted into a beneficial protective mechanism. Antioxidants are added that preferentially react with oxygen and other oxidizing agents, sacrificing themselves to protect the corticosteroid drug from oxidation and pH degradation throughout storage

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method effectively maintains pH stability for over six months, ensuring the efficacy of corticosteroid compositions by preventing the formation of acidic degradation products and enhancing drug solubility and bioavailability.

Implementation Method 1

the addition of an additive to prevent oxidation of the corticosteroid

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS12403147B2Treatment of ocular inflammation following ocular surgery
Publication Date: 2025.09.02 OCULIS OPERATIONS SARL

AI summary

The present disclosure relates to a method for stabilizing the pH of an aqueous composition comprising a drug which is prone to oxidation, said method comprising the addition of an additive to prevent oxidation of the drug which is prone to oxidation. In particular, the present disclosure relates to a method for stabilizing the pH of an aqueous composition comprising a corticosteroid, said method comprising the addition of an additive to prevent oxidation of the corticosteroid. The present disclosure also relates to a composition comprising a corticosteroid and an additive to prevent oxidation of the corticosteroid.